nodes	percent_of_prediction	percent_of_DWPC	metapath
Dopamine—DRD5—Signaling Pathways—RPE65—age related macular degeneration	0.00227	0.00227	CbGpPWpGaD
Dopamine—DRD5—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00223	0.00223	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—RHO—age related macular degeneration	0.00219	0.00219	CbGpPWpGaD
Dopamine—SLC22A3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.0021	0.0021	CbGpPWpGaD
Dopamine—MAOA—Metabolism—NMNAT1—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Dopamine—SLC22A5—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00209	0.00209	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—RHO—age related macular degeneration	0.00208	0.00208	CbGpPWpGaD
Dopamine—DRD4—G alpha (i) signalling events—C3—age related macular degeneration	0.00207	0.00207	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—RDH8—age related macular degeneration	0.00201	0.00201	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—RHO—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—SLC16A8—age related macular degeneration	0.00199	0.00199	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—RHO—age related macular degeneration	0.00198	0.00198	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—RHO—age related macular degeneration	0.00195	0.00195	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00194	0.00194	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—RDH8—age related macular degeneration	0.00192	0.00192	CbGpPWpGaD
Dopamine—POU5F1—Developmental Biology—VEGFA—age related macular degeneration	0.00185	0.00185	CbGpPWpGaD
Dopamine—DRD3—G alpha (i) signalling events—C3—age related macular degeneration	0.00184	0.00184	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—ABCA4—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Dopamine—MAOA—Metabolism—ELOVL4—age related macular degeneration	0.00183	0.00183	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—RHO—age related macular degeneration	0.00179	0.00179	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—RHO—age related macular degeneration	0.00178	0.00178	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—RHO—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—NMNAT1—age related macular degeneration	0.00177	0.00177	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—RPE65—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Dopamine—DRD5—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00175	0.00175	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RDH8—age related macular degeneration	0.00173	0.00173	CbGpPWpGaD
Dopamine—HTR7—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00172	0.00172	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RDH8—age related macular degeneration	0.00171	0.00171	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—C3—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—RHO—age related macular degeneration	0.0017	0.0017	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—RPE65—age related macular degeneration	0.00168	0.00168	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—NMNAT1—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Dopamine—DRD4—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00165	0.00165	CbGpPWpGaD
Dopamine—SLC6A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00163	0.00163	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—RHO—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Dopamine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Dopamine—HTR1A—G alpha (i) signalling events—C3—age related macular degeneration	0.00161	0.00161	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—RHO—age related macular degeneration	0.00159	0.00159	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RDH8—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—ELOVL4—age related macular degeneration	0.00155	0.00155	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—RHO—age related macular degeneration	0.00154	0.00154	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RPE65—age related macular degeneration	0.00151	0.00151	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—RHO—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RPE65—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Dopamine—DBH—Metabolism—CD36—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RDH8—age related macular degeneration	0.00149	0.00149	CbGpPWpGaD
Dopamine—DRD1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00148	0.00148	CbGpPWpGaD
Dopamine—MAOA—Metabolism—SLC16A8—age related macular degeneration	0.00147	0.00147	CbGpPWpGaD
Dopamine—DRD3—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00146	0.00146	CbGpPWpGaD
Dopamine—SLC6A3—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—ELOVL4—age related macular degeneration	0.00144	0.00144	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—ABCA4—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Dopamine—DRD2—G alpha (i) signalling events—C3—age related macular degeneration	0.00141	0.00141	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RPE65—age related macular degeneration	0.00136	0.00136	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—RHO—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—ABCA4—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Dopamine—HTR7—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00135	0.00135	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Dopamine—DRD5—GPCR ligand binding—CCL2—age related macular degeneration	0.00133	0.00133	CbGpPWpGaD
Dopamine—MAOA—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00132	0.00132	CbGpPWpGaD
Dopamine—SLC22A2—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Dopamine—DBH—Metabolism—APOE—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—C3—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RDH8—age related macular degeneration	0.00131	0.00131	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RPE65—age related macular degeneration	0.0013	0.0013	CbGpPWpGaD
Dopamine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Dopamine—DRD4—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00129	0.00129	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00128	0.00128	CbGpPWpGaD
Dopamine—COMT—Metabolism—LIPC—age related macular degeneration	0.00127	0.00127	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—C3—age related macular degeneration	0.00126	0.00126	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—SLC16A8—age related macular degeneration	0.00125	0.00125	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—RHO—age related macular degeneration	0.00123	0.00123	CbGpPWpGaD
Dopamine—SLC22A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Dopamine—COMT—Metabolism—CETP—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—ABCA4—age related macular degeneration	0.00122	0.00122	CbGpPWpGaD
Dopamine—MAOB—Metabolism—LIPC—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—ABCA4—age related macular degeneration	0.0012	0.0012	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—RHO—age related macular degeneration	0.00118	0.00118	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—SLC16A8—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Dopamine—DRD1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Dopamine—MAOB—Metabolism—CETP—age related macular degeneration	0.00116	0.00116	CbGpPWpGaD
Dopamine—DRD3—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00115	0.00115	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RPE65—age related macular degeneration	0.00114	0.00114	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—C3—age related macular degeneration	0.00113	0.00113	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Dopamine—HTR1A—SIDS Susceptibility Pathways—VEGFA—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—C3—age related macular degeneration	0.00112	0.00112	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—ABCA4—age related macular degeneration	0.0011	0.0011	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—RHO—age related macular degeneration	0.00106	0.00106	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—ABCA4—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—RHO—age related macular degeneration	0.00105	0.00105	CbGpPWpGaD
Dopamine—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.00104	0.00104	CbGpPWpGaD
Dopamine—HTR7—GPCR ligand binding—CCL2—age related macular degeneration	0.00103	0.00103	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—LIPC—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—C3—age related macular degeneration	0.00102	0.00102	CbGpPWpGaD
Dopamine—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000999	0.000999	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.00099	0.00099	CbGpPWpGaD
Dopamine—DRD4—GPCR ligand binding—CCL2—age related macular degeneration	0.000982	0.000982	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—CETP—age related macular degeneration	0.000981	0.000981	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—C3—age related macular degeneration	0.000972	0.000972	CbGpPWpGaD
Dopamine—DRD5—GPCR downstream signaling—C3—age related macular degeneration	0.000961	0.000961	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—RHO—age related macular degeneration	0.000953	0.000953	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—ABCA4—age related macular degeneration	0.00092	0.00092	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—RHO—age related macular degeneration	0.000911	0.000911	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000911	0.000911	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000903	0.000903	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—TGFBR1—age related macular degeneration	0.000895	0.000895	CbGpPWpGaD
Dopamine—DRD1—GPCR ligand binding—CCL2—age related macular degeneration	0.000884	0.000884	CbGpPWpGaD
Dopamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000877	0.000877	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—C3—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Dopamine—DRD3—GPCR ligand binding—CCL2—age related macular degeneration	0.000873	0.000873	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.000865	0.000865	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—C3—age related macular degeneration	0.000853	0.000853	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—SQSTM1—age related macular degeneration	0.000812	0.000812	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000802	0.000802	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—RHO—age related macular degeneration	0.0008	0.0008	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000796	0.000796	CbGpPWpGaD
Dopamine—ADRB1—GPCR ligand binding—CCL2—age related macular degeneration	0.000795	0.000795	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000789	0.000789	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000774	0.000774	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000771	0.000771	CbGpPWpGaD
Dopamine—HTR1A—GPCR ligand binding—CCL2—age related macular degeneration	0.00076	0.00076	CbGpPWpGaD
Dopamine—MAOA—Metabolism—LIPC—age related macular degeneration	0.000754	0.000754	CbGpPWpGaD
Dopamine—HTR7—GPCR downstream signaling—C3—age related macular degeneration	0.000741	0.000741	CbGpPWpGaD
Dopamine—COMT—Metabolism—CD36—age related macular degeneration	0.000735	0.000735	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000731	0.000731	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CETP—age related macular degeneration	0.000728	0.000728	CbGpPWpGaD
Dopamine—DRD4—GPCR downstream signaling—C3—age related macular degeneration	0.000709	0.000709	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000705	0.000705	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000698	0.000698	CbGpPWpGaD
Dopamine—MAOB—Metabolism—CD36—age related macular degeneration	0.000697	0.000697	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—TGFBR1—age related macular degeneration	0.00069	0.00069	CbGpPWpGaD
Dopamine—DRD5—Signaling by GPCR—CCL2—age related macular degeneration	0.000683	0.000683	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000674	0.000674	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—C3—age related macular degeneration	0.000673	0.000673	CbGpPWpGaD
Dopamine—DRD2—GPCR ligand binding—CCL2—age related macular degeneration	0.000668	0.000668	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—TGFBR1—age related macular degeneration	0.000661	0.000661	CbGpPWpGaD
Dopamine—COMT—Metabolism—APOE—age related macular degeneration	0.000649	0.000649	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—C3—age related macular degeneration	0.000644	0.000644	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000642	0.000642	CbGpPWpGaD
Dopamine—DRD1—GPCR downstream signaling—C3—age related macular degeneration	0.000639	0.000639	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—LIPC—age related macular degeneration	0.000638	0.000638	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000636	0.000636	CbGpPWpGaD
Dopamine—DRD3—GPCR downstream signaling—C3—age related macular degeneration	0.00063	0.00063	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—SQSTM1—age related macular degeneration	0.000626	0.000626	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000625	0.000625	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CETP—age related macular degeneration	0.000615	0.000615	CbGpPWpGaD
Dopamine—MAOB—Metabolism—APOE—age related macular degeneration	0.000615	0.000615	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000603	0.000603	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—SQSTM1—age related macular degeneration	0.000599	0.000599	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000595	0.000595	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—LIPC—age related macular degeneration	0.000595	0.000595	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—CD36—age related macular degeneration	0.00059	0.00059	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—TGFBR1—age related macular degeneration	0.000587	0.000587	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—C3—age related macular degeneration	0.00058	0.00058	CbGpPWpGaD
Dopamine—ADRB1—GPCR downstream signaling—C3—age related macular degeneration	0.000574	0.000574	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CETP—age related macular degeneration	0.000574	0.000574	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—C3—age related macular degeneration	0.000572	0.000572	CbGpPWpGaD
Dopamine—HTR1A—GPCR downstream signaling—C3—age related macular degeneration	0.000549	0.000549	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000543	0.000543	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000539	0.000539	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000535	0.000535	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—SQSTM1—age related macular degeneration	0.000532	0.000532	CbGpPWpGaD
Dopamine—HTR7—Signaling by GPCR—CCL2—age related macular degeneration	0.000527	0.000527	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—C3—age related macular degeneration	0.000521	0.000521	CbGpPWpGaD
Dopamine—SLC22A3—Metabolism—APOE—age related macular degeneration	0.00052	0.00052	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—C3—age related macular degeneration	0.000516	0.000516	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—TGFBR1—age related macular degeneration	0.000512	0.000512	CbGpPWpGaD
Dopamine—DRD4—Signaling by GPCR—CCL2—age related macular degeneration	0.000504	0.000504	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—C3—age related macular degeneration	0.000499	0.000499	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000485	0.000485	CbGpPWpGaD
Dopamine—DRD2—GPCR downstream signaling—C3—age related macular degeneration	0.000482	0.000482	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—APOE—age related macular degeneration	0.00048	0.00048	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—KDR—age related macular degeneration	0.00047	0.00047	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000465	0.000465	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—SQSTM1—age related macular degeneration	0.000464	0.000464	CbGpPWpGaD
Dopamine—DRD1—Signaling by GPCR—CCL2—age related macular degeneration	0.000454	0.000454	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000449	0.000449	CbGpPWpGaD
Dopamine—DRD3—Signaling by GPCR—CCL2—age related macular degeneration	0.000448	0.000448	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—C3—age related macular degeneration	0.000438	0.000438	CbGpPWpGaD
Dopamine—MAOA—Metabolism—CD36—age related macular degeneration	0.000437	0.000437	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000424	0.000424	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00041	0.00041	CbGpPWpGaD
Dopamine—ADRB1—Signaling by GPCR—CCL2—age related macular degeneration	0.000408	0.000408	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000407	0.000407	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—CCL2—age related macular degeneration	0.000403	0.000403	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—C3—age related macular degeneration	0.000398	0.000398	CbGpPWpGaD
Dopamine—HTR1A—Signaling by GPCR—CCL2—age related macular degeneration	0.00039	0.00039	CbGpPWpGaD
Dopamine—MAOA—Metabolism—APOE—age related macular degeneration	0.000386	0.000386	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—C3—age related macular degeneration	0.000381	0.000381	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000374	0.000374	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—APOE—age related macular degeneration	0.00037	0.00037	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—CD36—age related macular degeneration	0.00037	0.00037	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—KDR—age related macular degeneration	0.000363	0.000363	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000362	0.000362	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000357	0.000357	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—APOE—age related macular degeneration	0.000354	0.000354	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—KDR—age related macular degeneration	0.000347	0.000347	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—CD36—age related macular degeneration	0.000345	0.000345	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000344	0.000344	CbGpPWpGaD
Dopamine—DRD2—Signaling by GPCR—CCL2—age related macular degeneration	0.000343	0.000343	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—C3—age related macular degeneration	0.000343	0.000343	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—C3—age related macular degeneration	0.000338	0.000338	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000328	0.000328	CbGpPWpGaD
Dopamine—SLC22A2—Metabolism—APOE—age related macular degeneration	0.000326	0.000326	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000326	0.000326	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00032	0.00032	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—APOE—age related macular degeneration	0.000319	0.000319	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000317	0.000317	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—APOE—age related macular degeneration	0.000315	0.000315	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000314	0.000314	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—KDR—age related macular degeneration	0.000312	0.000312	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—CCL2—age related macular degeneration	0.000311	0.000311	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—KDR—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—C3—age related macular degeneration	0.000308	0.000308	CbGpPWpGaD
Dopamine—SLC22A1—Metabolism—APOE—age related macular degeneration	0.000304	0.000304	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—CCL2—age related macular degeneration	0.000298	0.000298	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—C3—age related macular degeneration	0.000295	0.000295	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—APOE—age related macular degeneration	0.000287	0.000287	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—KDR—age related macular degeneration	0.000281	0.000281	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000278	0.000278	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—APOE—age related macular degeneration	0.000274	0.000274	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—KDR—age related macular degeneration	0.000269	0.000269	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000268	0.000268	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—CCL2—age related macular degeneration	0.000268	0.000268	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—CCL2—age related macular degeneration	0.000265	0.000265	CbGpPWpGaD
Dopamine—DRD5—Signaling Pathways—VEGFA—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—C3—age related macular degeneration	0.000259	0.000259	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—CCL2—age related macular degeneration	0.000241	0.000241	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—APOE—age related macular degeneration	0.000241	0.000241	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—KDR—age related macular degeneration	0.000236	0.000236	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—CCL2—age related macular degeneration	0.000231	0.000231	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000207	0.000207	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—CCL2—age related macular degeneration	0.000202	0.000202	CbGpPWpGaD
Dopamine—HTR7—Signaling Pathways—VEGFA—age related macular degeneration	0.0002	0.0002	CbGpPWpGaD
Dopamine—DRD4—Signaling Pathways—VEGFA—age related macular degeneration	0.000191	0.000191	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—CD36—age related macular degeneration	0.00019	0.00019	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—CD36—age related macular degeneration	0.000189	0.000189	CbGpPWpGaD
Dopamine—CYP2C19—Metabolism—APOE—age related macular degeneration	0.000183	0.000183	CbGpPWpGaD
Dopamine—DRD1—Signaling Pathways—VEGFA—age related macular degeneration	0.000172	0.000172	CbGpPWpGaD
Dopamine—DRD3—Signaling Pathways—VEGFA—age related macular degeneration	0.00017	0.00017	CbGpPWpGaD
Dopamine—CYP2D6—Metabolism—APOE—age related macular degeneration	0.000168	0.000168	CbGpPWpGaD
Dopamine—CYP2C9—Metabolism—APOE—age related macular degeneration	0.000167	0.000167	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—CD36—age related macular degeneration	0.000161	0.000161	CbGpPWpGaD
Dopamine—ADRB1—Signaling Pathways—VEGFA—age related macular degeneration	0.000155	0.000155	CbGpPWpGaD
Dopamine—HTR1A—Signaling Pathways—VEGFA—age related macular degeneration	0.000148	0.000148	CbGpPWpGaD
Dopamine—CYP1A2—Metabolism—APOE—age related macular degeneration	0.000142	0.000142	CbGpPWpGaD
Dopamine—DRD2—Signaling Pathways—VEGFA—age related macular degeneration	0.00013	0.00013	CbGpPWpGaD
